By inhibiting Chk2 activity, Chk2 inhibitors can sensitize tumor cells to DNA-damaging agents, induce cell cycle arrest and apoptosis, and enhance the efficacy of conventional cancer treatments, such as chemotherapy and radiation therapy [45]. The gene discussed is CHEK2; the disease is neoplasm.